Mesoporous bioactive glass nanoparticles (MBGNPs) containing therapeutic ions have shown significant promise in the realm of hard and soft tissue repair and regeneration, owing to their multifunctional biological properties. In this study, gallium-incorporated silica-based gallium incorporated MBGNPs (Ga-MBGNPs) with fixed amount of Li2O (8 mol %) were synthesized using an emulsion-assisted sol-gel method. The impact of Ga2O3 integration into the silicate glass network was evaluated by investigating the microtextural properties. The results confirmed the production of spherical-shaped, nano-sized, amorphous particles with an enhanced specific surface area and ordered hexagonal meso-porosity (10–20 nm) in the developed Ga-MBGNPs. The in vitro bioactivity, assessed through hydroxyapatite (HAp) layer formation in simulated body fluid (SBF), over varying time intervals (0, 1, 3, 7, 14 & 21 days), revealed pronounced formation of short rod-like carbonated HAp with increasing immersion time and Ga3+ content in all glasses. However, a delayed apatite formation was observed for composition-dependent Ga-4 and Ga-5 MBGs during the initial incubation periods (1, 3, and 7 days). Further, the presence of Li + ions along with Ga3+ enhanced the apatite deposition when compared with the only Ga3+ inclusion. Evaluation of degradation rate and pH values indicated enhanced apatite formation with lower Ga ion content, while a slight reduction was noted with higher Ga ion content, attributable to the presence of reactive Si–O–Si bonds. Furthermore, analysis using a Zeta potential analyzer confirmed the dispersibility and bioreactivity of all glass powders owing to their higher negative surface charge. Moreover, Ga-MBGNPs exhibited notable antimicrobial effects against both E. coli and S. aureus bacteria due to the release of Ga3+ ions. Overall, the findings suggest that the incorporation of Ga in MBGNPs renders them potential multifunctional candidates for expediting the healing of bone tissue injuries in biomedical applications.